Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose sifuvirtide safety and pharmacokinetics study in HIV-infected adults
ChiCTR-TRC-08000211Phase 2Completed
- Sponsor
- Beijing YouAn Hospital
- Start
- Aug 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of sifuvirtide in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoints: Safety indexes and Pharmacokinetics indexes. Started Aug 2006; status: completed.
02
Drugs
sifuvirtide
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on ChiCTR-TRC-08000211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000211.